Skip to main content
Premium Trial:

Request an Annual Quote

Kailos PGxComplete

Kailos has launched PGxComplete, a comprehensive, full panel, gene-based test that the company is offering for $99 through November 30. The panel tests 20 different classes of medications to reveal how one's body responds to more than 50 types of medications, including antidepressants, opioids, HIV/AIDS treatment, and cancer therapy. The panel uses advanced technology that harnesses DNA sequencing and enables a more holistic view of a person's gene-based medical information, said Kailos in a statement. The company launched its first pharmacogenetics test (the Kailos test, formerly called Praxis) this past June. 

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more